Summary:
A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia. This study will evaluate the safety and tolerability of aripiprazole lauroxil (also known as ARISTADA, ALKS 9070).
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have demonstrated tolerability to test doses of oral aripiprazole during screening: OR
Have a history of tolerated use of aripiprazole
•
Have a diagnosis of schizophrenia
Qualified Participants May Receive:
Study-related medical care and investigational medication at no cost and may be compensated for time and travel.